Menu
Recruiting NCT06739174

Assessment of Colostomy Bags With an Active Chamber Filter System and Incidence of Filter-Related Complication

No phase Interventional Colostomy - Stoma Colostomy Complications

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Confidence Be 1-Piece Closed Bag, Confidence Natural 1-Piece Closed Bag, Confidence Be go 1-Piece Closed Bag.
Who it may be relevant to
Registry conditions: Colostomy - Stoma, Colostomy Complications. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Three Way Crossover Study: Assessment of Colostomy Bags With an Active Chamber Filter System and Incidence of Filter-Related Complication by People Living With a Colostomy

Overview

This 3-way crossover study aims to evaluate whether colostomy bags with an active chamber filter system reduce the incidence of filter-related complications, such as ballooning and pancaking, help neutralise odour, and minimise faecal leakage through the filter compared to colostomy bags with a protective filter

Detailed description

The study will recruit participants living with a colostomy who experience complications related to colostomy bag filters. The study follows a repeated-measures design, in which each participant will test three types of colostomy bags (A, B, and C) over a 21-day period, divided into three 7-day test periods. During each test period, participants will use one type of colostomy bag for 7-days or up to 21 closed bags. Participants will be instructed to change the colostomy bag as often as they normally would or whenever they deem it necessary

Interventions

  • Device Confidence Be 1-Piece Closed Bag
    Active Chamber Filter - Circle Shape
  • Device Confidence Natural 1-Piece Closed Bag
    Protective Filter - Circle Shape
  • Device Confidence Be go 1-Piece Closed Bag
    Active Chamber Filter - Hexagon Shape

Primary outcome measures

  • Incidence of ballooning [Time frame: 21-days]
Secondary outcome measures (7)
  • Time of ballooning incidence [Time frame: 21-days]
  • Wear time until ballooning incidence [Time frame: 21-days]
  • Incidence of pancaking [Time frame: 21-days]
  • Time of pancaking incidence [Time frame: 21-days]
  • Wear time until pancaking incidence [Time frame: 21-days]
  • Faecal leakage occurrence through the filter [Time frame: 21-days]
  • Occurrence of odour through the filter [Time frame: 21-days]

Eligibility criteria

Inclusion criteria

  • Adult aged over 18 years
  • Colostomy for 6 months or longer
  • Experiences any filter-related complications, such as ballooning, pancaking, odour, or faecal leakage through the filter, at least once a week (7 days)
  • Independent in colostomy care
  • Using a flat, closed colostomy bag
  • Stoma size (diameter) less than 55 mm
  • Using a colostomy bag with a hydrocolloid wafer (baseplate)
  • Able to read and complete the study questionnaire in English

Exclusion criteria

  • Uses colostomy irrigation
  • Bleeding or broken peristomal skin
  • Receiving or had radiotherapy or chemotherapy in the last 2 months
  • Pregnant or breastfeeding
  • Taking part in another clinical study
  • Currently receiving treatment under the care of a stoma clinical nurse specialist

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Supportive care

Study locations

United Kingdom · 1 center
  • Central Skin Sciences Institute (CSSI) Salts Healthcare — Birmingham

Identifiers

NCT: NCT06739174 · 24/EE/0241

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗